Macpril H 5 Tablet is a combination antihypertensive medication containing Ramipril 5 mg and Hydrochlorothiazide 12.5 mg. Ramipril, an angiotensin-converting enzyme (ACE) inhibitor, works by inhibiting the conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced blood pressure, and decreased workload on the heart. Hydrochlorothiazide, a thiazide diuretic, promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal renal tubules, thereby reducing blood volume and contributing to blood pressure reduction. This combination is indicated for the management of hypertension, especially in patients who require multiple mechanisms to achieve adequate blood pressure control. Macpril H 5 Tablet may also be beneficial in reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure in hypertensive patients. It is important to monitor renal function, electrolytes, and blood pressure regularly during therapy due to potential side effects such as hyperkalemia, hypotension, and electrolyte imbalances. Contraindications include hypersensitivity to ACE inhibitors or thiazides, pregnancy, and severe renal impairment. Patients should be advised to maintain adequate hydration and report any signs of angioedema or persistent cough promptly. Macpril H 5 offers a synergistic approach to hypertension management, improving patient compliance through combination therapy.